MARY’S STORY – PRESERVING LIFE INSURANCE TAX SAVINGS OF $1.4M
Mary and her husband operated a successful family business, which is now in the capable hands of their children and grandchildren. But with Mary in her 90s and failing health, her advisors wanted to review her corporate life insurance policies purchased in the early 1980s.
It was not an easy task considering the actual sales agent of the policies had since died, the policies had not been reviewed in over 30 years, and both the client and insurer held insufficient paperwork. Our advisors were asked to confirm […]
To our valued customers,
Our team is taking determined action to protect the health and safety of our employees so that we can continue to deliver best-in-class service, expert advice and support to our customers.
We have implemented a work-from-home schedule, with fewer staff working in our office. To further safeguard our employees, we are following the guidelines and advice from the Public Health Agency of Canada (PHAC). We are also encouraging employees to reach out for assistance when needed.
We’re in this with you.
While we meet the challenges of a global […]
Dehoney Financial Group (DFG) is pleased to announce Alain Bergeron has joined our team in the role of Chief Operating Officer as of November 12, 2019. Alain joins DFG with a wealth of experience working in the group benefits and insurance industries, predominantly with a large Canadian insurer where he was instrumental in its growth throughout Western Canada.
Building on a successful business and customer service model, Alain will focus on strategic business improvements and their execution. Alain will help bring to life the vision of DFG President and Founder Jim Dehoney by aligning the firm’s resources and applying […]
Over two years ago, the federal government announced that the rules governing the pricing of pharmaceuticals in Canada were changing. Now, after a lengthy public consultation process with interested Canadians and stakeholders, including the pharmaceutical industry, the Government of Canada has announced the final amendments to the Patented Medicines Regulations aimed at saving “Canadians billions over the next decade.”
The Patented Medicine Prices Review Board (PMPRB) has introduced the following amendments:
In setting drug prices, a “basket” of 11 other countries (no longer including the US and Switzerland), that are similar to Canada’s population, economy and approach […]